HK1039576A1 - 作為癌症和前列腺疾病的治療劑的新的多元胺類似物綴合物和醌綴合物 - Google Patents

作為癌症和前列腺疾病的治療劑的新的多元胺類似物綴合物和醌綴合物

Info

Publication number
HK1039576A1
HK1039576A1 HK02101270.7A HK02101270A HK1039576A1 HK 1039576 A1 HK1039576 A1 HK 1039576A1 HK 02101270 A HK02101270 A HK 02101270A HK 1039576 A1 HK1039576 A1 HK 1039576A1
Authority
HK
Hong Kong
Prior art keywords
conjugates
cancers
therapies
prostate diseases
prostate
Prior art date
Application number
HK02101270.7A
Other languages
English (en)
Inventor
Frydman Benjamin
J Marton Laurence
Original Assignee
Cellgate Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/011542 external-priority patent/WO2000066175A2/en
Application filed by Cellgate Inc filed Critical Cellgate Inc
Publication of HK1039576A1 publication Critical patent/HK1039576A1/zh

Links

HK02101270.7A 1999-04-30 2002-02-21 作為癌症和前列腺疾病的治療劑的新的多元胺類似物綴合物和醌綴合物 HK1039576A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13180999P 1999-04-30 1999-04-30
PCT/US2000/011542 WO2000066175A2 (en) 1999-04-30 2000-04-27 Conjugates as therapies for cancer and prostate diseases
US24680400P 2000-11-08 2000-11-08

Publications (1)

Publication Number Publication Date
HK1039576A1 true HK1039576A1 (zh) 2002-05-03

Family

ID=71727048

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101270.7A HK1039576A1 (zh) 1999-04-30 2002-02-21 作為癌症和前列腺疾病的治療劑的新的多元胺類似物綴合物和醌綴合物

Country Status (1)

Country Link
HK (1) HK1039576A1 (zh)

Similar Documents

Publication Publication Date Title
IL146126A0 (en) Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
EP1076568A4 (en) NON-INVASIVE PROCEDURE FOR DETECTING PROSTATE CANCER
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
EP0926955A4 (en) Conjugates useful in the treatment of prostate cancer
AU7994200A (en) Compositions and methods for therapy and diagnosis of prostate cancer
AU1123202A (en) Targeted alpha particle therapy using actinium-225 conjugates
HK1024876A1 (en) Conjugates useful in the treatment of prostate cancer
IL206604A0 (en) Transmembrane protein expressed in prostate cancer
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
IL136167A0 (en) Conjugates useful in the treatment of prostate cancer
EG22346A (en) Process for the preparation of conjugates useful in the treatment of prostate cancer
EP1208232A4 (en) PROSTATE CANCER MARKERS
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
ZA9810974B (en) Conjugates useful in the treatment of prostate cancer
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
HK1041832A1 (zh) 血紅蛋白-抗氧化劑輟合物
HK1039576A1 (zh) 作為癌症和前列腺疾病的治療劑的新的多元胺類似物綴合物和醌綴合物
AU4452900A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
IL142273A0 (en) Testis specific proteins expressed in prostate cancer
GB9804399D0 (en) Conjugates useful in the treatment of prostate cancer
GB9815855D0 (en) Conjugates useful in the treatment of prostate cancer
GB9810183D0 (en) Conjugates useful in the treatment of prostate cancer
GB9718160D0 (en) Conjugates useful in the treatment of prostate cancer

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: CELLGATE, INC.

Free format text: FORMER OWNER(S): SLIL BIOMEDICAL CORPORATION